Page last updated: 2024-09-03

ud cg 212 cl and ridogrel

ud cg 212 cl has been researched along with ridogrel in 1 studies

Compound Research Comparison

Studies (ud cg 212 cl)	Trials (ud cg 212 cl)	Recent Studies (post-2010) (ud cg 212 cl)	Studies (ridogrel)	Trials (ridogrel)	Recent Studies (post-2010) (ridogrel)
28	2	0	90	10	1

Protein Interaction Comparison

Protein	Taxonomy	ridogrel (IC50)
Thromboxane A2 receptor	Homo sapiens (human)	2.48
Thromboxane-A synthase	Homo sapiens (human)	0.0062
Thromboxane-A synthase	Rattus norvegicus (Norway rat)	0.006

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arnout, J; Deckmyn, H; Hoet, B; Vermylen, J	1

Other Studies

1 other study(ies) available for ud cg 212 cl and ridogrel

Article	Year
Synergistic antiplatelet effect of ridogrel, a combined thromboxane receptor antagonist and thromboxane synthase inhibitor, and UDCG-212, a cAMP-phosphodiesterase inhibitor. Thrombosis and haemostasis, 1993, Nov-15, Volume: 70, Issue:5 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blood Platelets; Collagen; Cyclic AMP; Drug Synergism; Humans; Pentanoic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridazines; Pyridines; Receptors, Thromboxane; Thromboxane-A Synthase	1993

Article

Year

Synergistic antiplatelet effect of ridogrel, a combined thromboxane receptor antagonist and thromboxane synthase inhibitor, and UDCG-212, a cAMP-phosphodiesterase inhibitor.

Thrombosis and haemostasis, 1993, Nov-15, Volume: 70, Issue:5

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blood Platelets; Collagen; Cyclic AMP; Drug Synergism; Humans; Pentanoic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridazines; Pyridines; Receptors, Thromboxane; Thromboxane-A Synthase

1993